These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24915402)

  • 1. Inhibition of Angiotensin Converting Enzyme, Angiotensin II Receptor Blocking, and Blood Pressure Lowering Bioactivity across Plant Families.
    Patten GS; Abeywardena MY; Bennett LE
    Crit Rev Food Sci Nutr; 2016; 56(2):181-214. PubMed ID: 24915402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant food-derived Angiotensin I converting enzyme inhibitory peptides.
    Guang C; Phillips RD
    J Agric Food Chem; 2009 Jun; 57(12):5113-20. PubMed ID: 19449887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological interventions into the renin-angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering.
    Düsing R
    Ther Adv Cardiovasc Dis; 2016 Jun; 10(3):151-61. PubMed ID: 27122491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effects of isoquercitrin and extracts from Tropaeolum majus L.: evidence for the inhibition of angiotensin converting enzyme.
    Gasparotto Junior A; Gasparotto FM; Lourenço EL; Crestani S; Stefanello ME; Salvador MJ; da Silva-Santos JE; Marques MC; Kassuya CA
    J Ethnopharmacol; 2011 Mar; 134(2):363-72. PubMed ID: 21185932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of natural peptides from food proteins on angiotensin converting enzyme activity and hypertension.
    Martin M; Deussen A
    Crit Rev Food Sci Nutr; 2019; 59(8):1264-1283. PubMed ID: 29244531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists.
    Campbell DJ
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S125-31. PubMed ID: 8993851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.
    Ruilope L
    J Hypertens Suppl; 1997 Dec; 15(7):S15-20. PubMed ID: 9532516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytotherapy of Hypertension: An Updated Overview.
    Ajebli M; Eddouks M
    Endocr Metab Immune Disord Drug Targets; 2020; 20(6):812-839. PubMed ID: 31880255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hancornia speciosa Gomes induces hypotensive effect through inhibition of ACE and increase on NO.
    Silva GC; Braga FC; Lima MP; Pesquero JL; Lemos VS; Cortes SF
    J Ethnopharmacol; 2011 Sep; 137(1):709-13. PubMed ID: 21756990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do angiotensin II receptor antagonists affect blood pressure?
    de Leeuw PW
    Am J Cardiol; 1999 Jul; 84(2A):5K-6K. PubMed ID: 10437737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of ACE inhibitors versus AT1 blockers.
    Vaughan D
    Can J Cardiol; 2000 Aug; 16 Suppl E():36E-40E. PubMed ID: 10906625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antihypertensive hexa- and heptapeptides with ACE-inhibiting properties: from the in vitro ACE assay to the spontaneously hypertensive rat.
    Ruiz-Giménez P; Marcos JF; Torregrosa G; Lahoz A; Fernández-Musoles R; Valles S; Alborch E; Manzanares P; Salom JB
    Peptides; 2011 Jul; 32(7):1431-8. PubMed ID: 21605609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive activity of Salvia elegans Vahl. (Lamiaceae): ACE inhibition and angiotensin II antagonism.
    Jiménez-Ferrer E; Badillo FH; González-Cortazar M; Tortoriello J; Herrera-Ruiz M
    J Ethnopharmacol; 2010 Jul; 130(2):340-6. PubMed ID: 20488233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
    Li GH; Qu MR; Wan JZ; You JM
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():275-80. PubMed ID: 17392118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Blood Pressure Lowering With Different Antihypertensive Agents on Cognitive Function and Plasma Brain-derived Neurotrophic Factor Levels: A Comparative Study.
    Demir M; Gürol AO; Özyiğit RT; Üresin AY
    J Cardiovasc Pharmacol; 2016 Jun; 67(6):538-43. PubMed ID: 26906033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.